Related Experiment Video

Updated: Jul 17, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation

Giuseppe De Luca1, Harry Suryapranata, Jan Paul Ottervanger

  • 1Divison of Cadiology, Ospedale Maggiore della Carità, Università del Piemonte Orientale A. Avogadro, Novara, Italy.

International Journal of Cardiology
|February 6, 2007
PubMed

Insights

Routine coronary stenting offers no significant clinical benefit over balloon angioplasty for elderly patients with ST-segment elevation myocardial infarction (STEMI). This finding suggests a need for individualized treatment approaches in this high-risk population.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Medicine

Background:

  • ST-segment elevation myocardial infarction (STEMI) treatment often involves coronary stenting.
  • While effective in younger populations, data on stenting benefits in elderly STEMI patients are limited.
  • Elderly STEMI patients represent a high-risk subgroup requiring specific treatment evaluation.

Purpose of the Study:

  • To evaluate the clinical benefits of routine coronary stenting versus balloon angioplasty in elderly patients (over 75 years) with STEMI.
  • To assess the impact of stenting on mortality, reinfarction, and major adverse cardiac events in this demographic.

Main Methods:

  • The Zwolle-6 randomized trial included 1683 STEMI patients randomized to stenting or balloon angioplasty.
  • A subgroup analysis focused on 143 patients aged 75 years or older.
  • One-year follow-up data were collected for all participants.

Main Results:

  • In patients over 75, no significant differences were observed in 1-year mortality (17.1% vs 11.9%), reinfarction (9.2% vs 11.9%), target vessel revascularization (15.8% vs 14.9%), or major adverse cardiac events (28.9% vs 26.9%) between stenting and balloon angioplasty groups.
  • Statistical analysis showed no significant difference (p=NS) for any of the primary or secondary endpoints.

Conclusions:

  • Routine coronary stenting does not appear to offer superior clinical benefits compared to balloon angioplasty in elderly patients with STEMI.
  • The established benefits of stenting in acute myocardial infarction may not directly translate to the elderly population.
  • Findings suggest that treatment decisions for STEMI in elderly patients should consider individual risk factors and may not universally favor stenting.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...